Short Interest in Sonova Holding (OTCMKTS:SONVY) Decreases By 74.8%

Sonova Holding (OTCMKTS:SONVY – Get Free Report) was the recipient of a large drop in short interest in the month of June. As of June 30th, there was short interest totaling 858 shares, a drop of 74.8% from the June 15th total of 3,402 shares. Based on an average daily volume of 54,140 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on SONVY shares. Citigroup reiterated a “sell” rating on shares of Sonova in a report on Wednesday, May 13th. Jefferies Financial Group lowered shares of Sonova from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, March 18th. Finally, Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a research note on Tuesday, June 23rd. Two research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Get Sonova alerts:

Check Out Our Latest Research Report on SONVY

Sonova Stock Performance

Shares of SONVY traded up $0.28 during midday trading on Monday, reaching $50.52. 8,106 shares of the stock were exchanged, compared to its average volume of 36,420. Sonova has a 52 week low of $42.26 and a 52 week high of $61.09. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. The company’s 50 day moving average is $49.38 and its two-hundred day moving average is $49.79.

Sonova Company Profile

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

See Also

• Five stocks we like better than Sonova
• Why Welltower’s Growth Story Might Outrun Its Rich Valuation
• One Short- and One Long-Term ETF for Quantum Computing Bulls
• The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
• Why Micron Is Doubling Down While the HBM Shortage Persists

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.